Filing Details
- Accession Number:
- 0001104659-24-023696
- Form Type:
- 13G Filing
- Publication Date:
- 2024-02-13 19:00:00
- Filed By:
- Qiming U.s. Healthcare Fund Ii, L.p.
- Company:
- Jasper Therapeutics Inc.
- Filing Date:
- 2024-02-14
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Qiming U.S. Healthcare Fund II | 0 | 928,964 | 928,964 | 928,964 | 6.2% | |
| Qiming U.S. Healthcare GP II | 0 | 928,964 | 928,964 | 928,964 | 6.2% | |
| Mark McDade | 0 | 928,964 | 928,964 | 928,964 | 6.2% | |
| Gary Rieschel | 0 | 928,964 | 928,964 | 928,964 | 6.2% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)
JASPER THERAPEUTICS, InC.
(Name of Issuer)
Voting Common Stock, par value $0.0001 per share
(Title of Class of Securities)
471871 202
(CUSIP Number)
December 31, 2023
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)